Tianjin Pharmaceutical Da Ren Tang Group (STU:2TZ) Institutional Ownership: 0.02% (As of Aug. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:2TZ Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd STU:2TZ
69 GF Score
Price €2.40
GF Value €1.54
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Tianjin Pharmaceutical Da Ren Tang Group Institutional Ownership?

Tianjin Pharmaceutical Da Ren Tang Group STU:2TZ 69 Institutional Ownership is 0.02% as of Aug. 08, 2026. GuruFocus rates STU:2TZ with a GF Score™ of 69/100 and a GF Value™ of €1.54 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Tianjin Pharmaceutical Da Ren Tang Group's institutional ownership is 0.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Tianjin Pharmaceutical Da Ren Tang Group's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Tianjin Pharmaceutical Da Ren Tang Group's Float Percentage Of Total Shares Outstanding is 0.00%.

Tianjin Pharmaceutical Da Ren Tang Group Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tianjin Pharmaceutical Da Ren Tang Group Institutional Ownership Chart

Tianjin Pharmaceutical Da Ren Tang Group Historical Data

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 0.06 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02
STU:2TZ
69GF Score
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd STU:2TZ
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tianjin Pharmaceutical Da Ren Tang Group Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.02% mean?
Tianjin Pharmaceutical Da Ren Tang Group (STU:2TZ) has a Institutional Ownership of 0.02% as of Aug. 08, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Tianjin Pharmaceutical Da Ren Tang Group and its competitors.
Is Tianjin Pharmaceutical Da Ren Tang Group's Institutional Ownership too high?
Tianjin Pharmaceutical Da Ren Tang Group's current Institutional Ownership is 0.02%. Overall, Tianjin Pharmaceutical Da Ren Tang Group has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tianjin Pharmaceutical Da Ren Tang Group's Institutional Ownership compare to ZTS?
Tianjin Pharmaceutical Da Ren Tang Group's Institutional Ownership of 0.02% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Tianjin Pharmaceutical Da Ren Tang Group and its competitors. Tianjin Pharmaceutical Da Ren Tang Group's current Institutional Ownership is 0.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tianjin Pharmaceutical Da Ren Tang Group stock overvalued right now?
Based on GuruFocus' analysis, Tianjin Pharmaceutical Da Ren Tang Group (STU:2TZ) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.54, compared to a current price of €2.40 — trading 55.8% above its estimated fair value. The current Institutional Ownership is 0.02%. Tianjin Pharmaceutical Da Ren Tang Group's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Tianjin Pharmaceutical Da Ren Tang Group (STU:2TZ), the current Institutional Ownership is 0.02% as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tianjin Pharmaceutical Da Ren Tang Group (STU:2TZ) Overvalued in 2026?

Based on GuruFocus' analysis, Tianjin Pharmaceutical Da Ren Tang Group stock appears to be overvalued. The current stock price of €2.40 is trading 55.8% above its estimated GF Value™ of €1.54. GuruFocus considers Tianjin Pharmaceutical Da Ren Tang Group to be Significantly Overvalued.

Key valuation signals for STU:2TZ:

  • Institutional Ownership: 0.02%
  • GF Value™: €1.54 vs. price of €2.40 (55.8% above fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the STU:2TZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tianjin Pharmaceutical Da Ren Tang Group Business Description

Other Exchanges T14:Singapore600329:China
Address No. 17 Baidi Road, Darentang Building, Nankai District, Tianjin, CHN, 300193
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company is engaged in the production and sale of traditional Chinese medicine, Western medicine, healthcare products, and investment holding. It operates in two segments, namely the Chinese Medicine segment and the Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures Western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese medicine.
69GF Score

Get the complete analysis for STU:2TZ

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.40
Price
€1.54
GF Value